Aug 2026· ASIDE Oncology· 0 citations· 20 references
TL;DR
A consistent rise in pancreatic cancer-related mortality with an increasing trend for rural areas emphasizes the discrepancy and the possible need for targeted interventions.
Abstract
Background: Pancreatic Cancer is the sixth deadliest cancer across the world, and its incidence has more than doubled in recent decades. The literature lacks comprehensive evidence on rural-urban and place-of-death mortality trends over the last two decades. This retrospective analysis summarizes the mortality trends for deaths involving pancreatic cancer patients from 1999 to 2023, with urban and rural stratification to better direct interventional strategies.
Methods: Data from death certificates were extracted using the CDC WONDER database's multiple cause-of-death model, using ICD-10 codes C25.0 to C25.4 and C25.7 to C25.9 for adults aged 25+ years from 1999 to 2023. The urbanization data were extracted from 1999 to 2020. Urbanization regions were organized, and age-adjusted mortality rates (AAMRs) were calculated per 100,000 population. Joinpoint software was used for evaluating trends.
Results: A total of 1,002,439 deaths from pancreatic cancer occurred from 1999 to 2023, with an overall increase in AAMR from 17.254 in 1999 to 18.446 in 2023 (AAPC: 0.3293%). The death rate in rural areas, though declining initially (APC: -0.2572%), has increased persistently since 2003 (APC: 0.773%), surpassing the urban death rate from 2010 onwards. The rise in urban fatality rates was less steep (AAPC: 0.20%). Place of death was analyzed as a cross-period distribution, with the majority of deaths occurring in the decedent’s home (48.3%), followed by medical facilities (25.19%) and nursing homes (11.26%).
Conclusion: A consistent rise in pancreatic cancer-related mortality with an increasing trend for rural areas emphasizes the discrepancy and the possible need for targeted interventions.
Introduction: The two leading causes of death worldwide are lung cancer and cerebrovascular disease (CVD). Due to complications related to the disease and therapy, patients with lung cancer are much more likely to have a stroke, particularly within 2 years after diagnosis. Results are still poor despite medical advance...
S. H. Shahab, Aown Abbas, Siddique Ahmed et al.· Annals of Medicine and Surge...· 0 citations
Background: Liver cell carcinoma (LCC) and hepatic failure (HF) are significant contributors to liver-related mortality in the United States. This study assessed LCC- and HF-related mortality trends (1999–2023) using CDC WONDER data, stratified by demographics and geography.
Methods: Deaths among U.S. adults aged ≥25 y...
S. Khan, Muneeb Khawar, Muhammad Haris Khan et al.· ASIDE Gastroenterology· 0 citations
Background As CRC survival improves, the shifting contributions of metastatic and non-cancer causes to mortality remain poorly characterized, with implications for survivorship care and public health policy. This study aimed to examine temporal trends in CRC mortality with selected contributing conditions from 1999 to...
Zi-Chen He, Ya-Dong Chen, Yu-Xing Hu et al.· Frontiers in Public Health· 0 citations
Background Gallbladder cancer (GBC) is a rare but highly lethal malignancy, often diagnosed at advanced stages due to the absence of early symptoms. Although its incidence is relatively low in the United States, marked demographic and geographic disparities persist, and long-term national mortality trends remain insuff...
Qiu Yang, Xu Chen, Yao Xiao et al.· Frontiers in Oncology· 0 citations
Background: U.S. mortality trends involving pancreatic cancer and pulmonary embolism (PE) and whether PE is becoming increasingly represented among pancreatic cancer deaths remain incompletely characterized. Methods: We analyzed CDC WONDER Multiple Cause of Death data for adults aged ≥ 25 years from 1999 through 2024....
A. Dhali, J. Biswas, Ali Shan Hafeez et al.· Diseases· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.